On July 17, Rocket Lab fell 5.42% in pre-market trading, trading at $63.69/share with turnover of $13.05 million, extending the prior session's decline.

On the news front, Piper Sandler initiated coverage of Rocket Lab with a \"Neutral\" rating and an $83 price target, well below the Wall Street consensus target of $119.07. The broker noted that while vertically integrated rocket manufacturers hold cost advantages, it is difficult to characterize Rocket Lab's valuation as \"cheap\" on a one-year horizon. Meanwhile, CEO Peter Beck sold approximately 2.8 million shares between July 6-8 under a pre-arranged 10b5-1 plan, with filings indicating plans to sell up to 5 million shares worth roughly $465 million.

Rocket Lab had previously rallied sharply following its announcement of an $8 billion acquisition of Iridium Communications and Morgan Stanley raising its bull-case target to $293. The stock is now in a profit-taking phase, with the conservative analyst initiation and concentrated insider selling reinforcing downward pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)